These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 23985881)
1. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice. Feng MH; Cui JC; Nakane A; Hu DL Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881 [TBL] [Abstract][Full Text] [Related]
2. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection. Cui JC; Hu DL; Lin YC; Qian AD; Nakane A FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection. Narita K; Hu DL; Asano K; Nakane A Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568 [TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection. Narita K; Hu DL; Tsuji T; Nakane A FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579 [TBL] [Abstract][Full Text] [Related]
9. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus. Asano K; Narita K; Hirose S; Nakane A Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843 [TBL] [Abstract][Full Text] [Related]
10. High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm. Roetzer A; Stich N; Model N; Schwameis M; Firbas C; Jilma B; Eibl MM Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33023185 [TBL] [Abstract][Full Text] [Related]
11. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1. Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671 [TBL] [Abstract][Full Text] [Related]
12. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Bonventre PF; Heeg H; Cullen C; Lian CJ Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Miethke T; Duschek K; Wahl C; Heeg K; Wagner H Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325 [TBL] [Abstract][Full Text] [Related]
14. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection. Hu DL; Omoe K; Narita K; Cui JC; Shinagawa K; Nakane A Microbes Infect; 2006; 8(14-15):2841-8. PubMed ID: 17090392 [TBL] [Abstract][Full Text] [Related]
15. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection. Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722 [TBL] [Abstract][Full Text] [Related]
16. Inverse relationship between toxic shock syndrome toxin-1 antibodies and interferon-γ and interleukin-6 in peripheral blood mononuclear cells from patients with pediatric tonsillitis caused by Staphylococcus aureus. Chen Y; Huang Y; Liang B; Dong H; Yao S; Xie Y; Long Y; Zhong H; Yang Y; Zhu B; Gong S; Zhou Z Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():211-217. PubMed ID: 28483238 [TBL] [Abstract][Full Text] [Related]
17. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice. Dinges MM; Schlievert PM Infect Immun; 2001 Mar; 69(3):1256-64. PubMed ID: 11179286 [TBL] [Abstract][Full Text] [Related]
18. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig. Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617 [TBL] [Abstract][Full Text] [Related]
19. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds. Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863 [TBL] [Abstract][Full Text] [Related]
20. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children. Quan L; Morita R; Kawakami S Burns; 2010 Aug; 36(5):716-21. PubMed ID: 20036064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]